SCHEMBL7126089

SCHEMBL7126089

CC(=O)OC(C1CCOC1=O)C1CC2C=CC1C2

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14252805 0.82
SCHEMBL7119984 0.80 KDM4E (0.32)
SCHEMBL7126364 0.78 KDM4E (0.32) ALDH1A1POLB
SCHEMBL9908405 0.75 HPGD (0.34) ALDH1A1POLB
SCHEMBL14625814 0.73
SCHEMBL13992888 0.70
SCHEMBL1087443 0.68 ALDH1A1 (0.36) ALDH1A1
SCHEMBL7130240 0.67 IDO1 (0.35) ALDH1A1
SCHEMBL3365813 0.65 ALDH1A1 (0.34) ALDH1A1
SCHEMBL12634094 0.64 TDP1 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6660448-B2 Lactone ring-substituted norbornene based polymers; photoresists; resolution, etching resistance, use in micropatterning with electron beams or deep-ultraviolet radation SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-12-09 US disclosed
US-6500961-B2 MICROSTRUCTURE PATTERNS FOR PHOTORESISTS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-12-31 US disclosed
US-20020091215-A1 Polymer, resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-07-11 US disclosed
US-20020019545-A1 Novel lactone compounds having alicyclic structure and their manufacturing method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019545-A1 Novel lactone compounds having alicyclic structure and their manufacturing method RACK1, MRPS22, ECH1 ALDH1A1 866/4885POLB 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.